Treatment of resting zone chondrocytes with transforming growth factor-β1 induces differentiation into a phenotype characteristic of growth zone chondrocytes by downregulating responsiveness to 24,25-(OH)2D3 and upregulating responsiveness to 1,25-(OH)2D3

This publication has 26 references indexed in Scilit:

• The Synergistic Effect of TGFβ and 24, 25-(OH)₂D₃on Resting Zone Chondrocytes is Metabolite-Specific and Mediated by PKC
  Connective Tissue Research, 1996
• Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes
  Endocrinology, 1995
• Regulation of protein kinase C by transforming growth factor β1 in rat costochondral chondrocyte cultures
  Journal of Bone and Mineral Research, 1994
• Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner
  Endocrinology, 1993
• Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor‐β in osteosarcoma cell cultures
  Journal of Cellular Physiology, 1990
• Transforming growth factor‐beta modulates the expression of osteoblast and chondroblast phenotypes in vitro
  Journal of Cellular Physiology, 1988
• Differential expression of phenotype by resting zone and growth region costochondral chondrocytes in vitro
  Bone, 1988
• Differentiation of rat mesenchymal cells by cartilage-inducing factor
  Experimental Cell Research, 1986
• Current Concepts of the Physiology and Biochemistry of Calcification
  Clinical Orthopaedics and Related Research, 1981
• Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins
  Biochemistry, 1971